Lansdale, PA, United States of America

Patricia Hey


Average Co-Inventor Count = 8.3

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2001-2007

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Patricia Hey: Innovator in Genetic Research

Introduction

Patricia Hey is a distinguished inventor based in Lansdale, PA (US). She has made significant contributions to the field of genetic research, holding a total of 4 patents. Her work primarily focuses on the implications of specific genes associated with type 1 diabetes and other autoimmune diseases.

Latest Patents

One of her latest patents is a method of screening for modulators of LRP5 activity. This invention introduces a novel receptor, LDL-receptor-related protein-5 (LRP-5), along with encoding nucleic acid. The gene is linked to type 1 diabetes (insulin-dependent diabetes mellitus), and experimental evidence suggests it is the IDDM susceptibility gene IDDM4. The invention encompasses various aspects, including nucleic acid, coding sequences, oligonucleotide primers and probes, polypeptides, pharmaceutical compositions, and methods of diagnosis or prognosis. It also provides methods related to the gene, including treatments for diseases such as autoimmune disorders, viral infections, and diabetes.

Another significant patent involves a novel receptor, LDL-receptor-related protein-3 (LRP-3), which also relates to type 1 diabetes. Similar to her previous work, this invention provides nucleic acid and various methods for diagnosis and treatment of diseases associated with the gene.

Career Highlights

Patricia has worked with prominent organizations, including Merck & Co., Inc. and The Wellcome Trust Limited as Trustee for the Wellcome Trust. Her experience in these institutions has allowed her to collaborate with leading experts in the field.

Collaborations

Some of her notable coworkers include John W. Hess and Michael S. Phillips. Their collaborative efforts have contributed to advancing research in genetic disorders and potential treatments.

Conclusion

Patricia Hey's innovative work in genetic research has led to significant advancements in understanding and treating type 1 diabetes and related diseases. Her contributions continue to impact the field and inspire future research endeavors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…